About: Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1996 (uk) im Januar 1996 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58868101-8FB14200-28A0-4BD9-8691-1D5914075B75
publication date	1996-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58868101-9F208D8B-F210-4143-BBBE-AE34E2251AEA
language of work or name	English
author name string	wds:Q58868101-B8481720-0959-4787-A125-1102FD6FA9C5 wds:Q58868101-EF069707-8239-4C05-B396-4F20DDCACCD5
author name string	Z Zhao G C Ness
rdfs:label	Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation (en) Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation (nl)
skos:prefLabel	Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation (en) Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation (nl)
name	Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation (en) Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation (nl)
author	wds:Q58868101-ADA328E5-7047-4D21-8C41-2A69939EC764
author	Dayami Lopez
title	wds:Q58868101-F0B3DB66-08F0-453B-9F85-95B7E5BD8423
title	Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation (en)
page(s)	wds:Q58868101-B8784CF2-B4D5-4BFF-A4D9-EACE8E4EAD9F
page(s)	242-248
instance of	wds:Q58868101-99617361-2ABC-484E-9C2C-9940BB2F03F2
instance of	scholarly article
main subject	wds:Q58868101-0B3AF247-6EA8-4C45-BDB0-2D8206035FFB
main subject	lipoprotein
PubMed ID	wds:Q58868101-7B827177-2E63-4C4C-9063-29A7BCBE57C3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8561503
PubMed ID	8561503
published in	wds:Q58868101-7482F3B4-62B4-4386-B12E-1D21C563ED25
published in	Archives of Biochemistry and Biophysics
issue	wds:Q58868101-06100DFD-0882-47EC-BF0D-0ED3731D1E45
volume	wds:Q58868101-2BF022CD-FA81-42C7-B12D-F060F3DEE0B9
issue	2
volume	325
DOI	wds:Q58868101-30042E46-4D78-47A4-B30F-69B373D6CD21
DOI	http://dx.doi.org/10.1006/ABBI.1996.0030
DOI	10.1006/ABBI.1996.0030
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58868101
is cites work of	Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol Development of the ACTH and corticosterone response to acute hypoxia in the neonatal rat Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 New drugs for the treatment of hypercholesterolaemia Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors A novel therapeutic effect of statins on nephrogenic diabetes insipidus The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans Effect of lycopene and tomato products on cholesterol metabolism Soluble LDL-R are formed by cell surface cleavage in response to phorbol esters Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink Cholesterol-cholate-butterfat diet offers multi-organ dysfunction in rats Mechanism of resistance to dietary cholesterol Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Effects of single administration of pravastatin sodium on hepatic cholesterol metabolism in rats Association of the low-density lipoprotein receptor with caveolae in hamster and rat liver Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats). Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits Differential effects of dietary fat on chick plasma and liver composition and HMG-CoA reductase activity Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1B hamster Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption Update on lipid-lowering therapy and LDL-cholesterol targets Effect of YM-53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters Even Cancer Cells Watch Their Cholesterol! Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia Pharmaceutical initiatives to combat atherosclerosis--what to do with the good, the bad, and the ugly lipoproteins Treatment of metabolic disorders with fluvastatin after renal transplantation Statins for non-alcoholic steatohepatitis Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
is cites work of	wds:Q27005638-63B84778-E323-40EE-AFC9-B29448D21493 wds:Q34911107-8EA1C12C-FF7B-4355-9CDB-AEF5420FF01D wds:Q40598692-C63395A5-44FB-4A4A-B7E0-0A7886EC209A wds:Q73292058-758432AA-FD9F-420C-9EE3-32DFFDC1EF88 wds:Q28564763-2A45172C-CF16-49A5-84CE-008116CCF0CD wds:Q28588292-8EC77203-06B1-4BBC-8A68-3733D1AD8BFB wds:Q35294753-BB86469B-59E4-4248-BE88-447113869139 wds:Q33899261-42908556-EF18-44B6-AA29-5279ECFC99C8 wds:Q36549639-0F4D378F-3AA5-4291-8EFB-BACF400BF9AF wds:Q41827579-F16BAC1F-59A5-416B-B2AA-632A7A0F4287 wds:Q90503839-0A277C0C-DFD1-4B43-8B8F-2A023E8A45A5 wds:Q35152907-D209CE87-9742-4E5C-9124-09768637D23E wds:Q38042332-6E33AA98-9DAD-4DCD-8DF8-A89EB6CCE0EC wds:Q47711765-0D099B1F-63F8-48E6-B194-14D050C44709 wds:Q73667298-526374A5-6A34-49FE-BD95-20714F7B67D4 wds:Q77933467-0AE7F3FD-2C57-4EE9-9563-C1E0408FF7BD wds:Q35023950-A91423A2-1FA4-46E9-8028-7BBB66EE636B wds:Q40565124-37AF5B56-CC8A-48BB-A49A-45FBA45313E1 wds:Q58868066-06E3D40D-1C97-431E-8DF2-CAE08BDC4B3D wds:Q73277859-35BCD1E4-9785-4A32-9026-BB47226E0B88 wds:Q73048430-454C3BEA-3DAB-4E82-9090-AFF9ECFD5B01 wds:Q24234628-2A2B62E6-B8E3-4C80-81D7-1C2BB16946AC

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software